Regulatory Considerations in the Approval of Rezafungin (REZZAYO) for the Treatment of Candidemia and Invasive Candidiasis in Adults.
Smith HL, Bensman TJ, Mishra S, Li X, Dixon CA, Sheikh J, McMaster OG, Joshi A, Rubin DB, Goodwin A, Miller TJ, Danielsen ZY, Syed I, Shukla SJ, Iarikov D, Kim PW, Farley JJ.
Smith HL, et al. Among authors: kim pw.
J Infect Dis. 2024 Mar 19:jiae146. doi: 10.1093/infdis/jiae146. Online ahead of print.
J Infect Dis. 2024.
PMID: 38502709